Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

PHAL426 Clinical Pharmacology

This is a paper in clinical pharmacology and, as such, focuses on the pharmacological management of some of the prominent disease states in humans. Aspects covered include indications for chemotherapy, adverse effects, drug-drug interactions, pharmacokinetic parameters that affect dose regimens and how recent research has impacted on the clinical management of patients. This is not a paper in experimental pharmacology. Seminar topics will cover health issues that are relevant to New Zealand at the present time. Class time will include presentations from clinicians and scientists involved in the care of patients and study of disease, but student involvement is an integral part of this paper. Each session will provide a unique opportunity to discuss various aspects of clinical pharmacology. You will be required to present information derived through literature searches. This information may be presented in the form of a PowerPoint presentation or as accompanying notes. There will be specified sessions in which this work will be assessed.

Paper title Clinical Pharmacology
Paper code PHAL426
Subject Pharmacology
EFTS 0.1667
Points 20 points
Teaching period Full Year
Domestic Tuition Fees (NZD) $1,622.82
International Tuition Fees (NZD) $6,017.70

^ Top of page

Teaching staff
Associate Professor Ivan Sammut

Textbooks are not required for this paper.

Graduate Attributes Emphasised
Interdisciplinary perspective, Lifelong learning, Scholarship, Communication, Critical thinking, Cultural understanding, Ethics, Environmental literacy, Research, Self-motivation.
View more information about Otago's graduate attributes.
Learning Outcomes
This paper is based primarily on seminar sessions. The module is designed so as to allow you to work in teams to discuss and evaluate recent clinical trial reports and identify potential flaws or biases in the study design.

A series of major disease topics (diabetes, HIV, heart failure, etc.) will serve as the core topics, with material on the pathophysiological aspects underlining each disease delivered by specialist lecturers. Case-based learning will be used to deliver and reinforce concepts of pathology and presentation specific to each disease. You will be expected to apply research skills to the critical evaluation of clinical study reports.

By the end of the paper you should be able to:
  • Consolidate your earlier undergraduate knowledge of the pharmacokinetic and pharmacodynamic properties of each major drug class
  • Identify the major classes of drugs used to treat or prevent specific diseases and detail their mechanisms of action
  • Identify the most common adverse effects of each drugs class
  • Describe how age, genetic difference or disease may require adjustments in dosing regimens
  • Identify common drug interactions
  • Begin to evaluate scientific data from clinical trials

^ Top of page


Full Year

Teaching method
This paper is taught On Campus
Learning management system


Stream Days Times Weeks
A1 Thursday 10:00-11:50 9-16, 18-22
B1 Thursday 10:00-11:50 28-34, 36-41